Wedoany.com Report-Oct. 25, Symrise AG, based in Holzminden, Germany, announced a strategic equity investment in U.S.-based biotechnology company Cellibre, strengthening its position in sustainable biomanufacturing. The partnership focuses on fermentation-derived ingredients across taste solutions and cosmetic actives, reinforcing Symrise’s long-term competitiveness and sustainability leadership.

Through this collaboration, Symrise gains preferred access to Cellibre’s proprietary fermentation-based technology, enabling scalable production of high-value ingredients for the food, beverage, cosmetics, and nutraceutical sectors. The investment is intended to enhance supply chain resilience, mitigating risks from seasonal or cultivation variability. This initiative follows Symrise’s recent partnership with Aplantex in fermentation-based chemicals.

Imke Meyer, Project Lead for Biotechnology at Symrise, stated: “This investment accelerates our biotechnology roadmap and strengthens our ability to deliver sustainable, high-quality solutions to our customers. Together with Cellibre, we will combine scientific expertise with application know-how and market reach to unlock new growth opportunities.”

Cellibre, established in 2017, specializes in designing and engineering microorganisms to produce cultured natural products and chemicals used in pharmaceuticals, functional health, beauty ingredients, industrial applications, and more. Ben Chiarelli, CEO of Cellibre, said: “Since 2017, we have been led by the belief that biology is the future of manufacturing and we are committed to creating more resilient supply chains, delivering products that are lower cost and higher quality while limiting the impact on natural ecosystems. This partnership represents another external validation of our approach, technology, and team, and will leverage the Symrise team’s global market access and deep expertise in flavors, fragrances and cosmetics — creating powerful synergies for both companies.”

The collaboration allows Symrise to integrate biotechnology across its operations, supporting portfolio diversification, long-term resilience, and competitive advantage. It aligns with the company’s sustainability commitments and consumer-driven innovation strategy. By combining Cellibre’s biotechnology platform with Symrise’s market reach and application expertise, the partnership aims to accelerate the development of fermentation-derived solutions that are both environmentally sustainable and commercially viable.

The strategic investment also emphasizes scalable production capabilities, which will help Symrise address growing demand for sustainable ingredients while ensuring consistent quality and supply. Both companies plan to leverage their combined knowledge to advance new products, enhance process efficiency, and expand into global markets.

Overall, the Symrise-Cellibre partnership underscores a growing industry trend toward biotechnology-driven solutions that reduce reliance on traditional raw materials, lower environmental impact, and meet consumer expectations for sustainable and high-quality products. This move positions Symrise at the forefront of innovation in sustainable flavors, fragrances, cosmetics, and related sectors.